Sugi Predict

Sugi Predict / Targets / ORC3

ORC3

Origin recognition complex subunit 3 · Q9UBD5 · ORC3 on Sugi Atlas →

0 patent compounds predicted against ORC3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ORC3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Proteome-based Immunotherapy of Lung Cancer Brain Metastases PHASE2/PHASE3UNKNOWN
Proteome-based Personalized Immunotherapy of Glioblastoma PHASE2/PHASE3UNKNOWN
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Genetic Polymorphism and Retinopathy of Prematurity: Correlation of Clinical Presentations and Severity nanUNKNOWN
Stress and Treatment Response in Puerto Rican Children With Asthma nanCOMPLETED
Defining an Obesity QTL on Chromosome 3q nanCOMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
Family Studies in Primary Biliary Cirrhosis (PBC) nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Diet, Genetics, and CVD Risk Factor Response in Blacks nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome nanUNKNOWN
Study of the Effect of Innate on the Inflammatory Response to Endotoxin nanRECRUITING
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ORC3 binder may also engage these)

ProteinNameSimilarity
Q5DJU3 — 1.000 Q5DJU3 →
Q32PJ3 — 1.000 Q32PJ3 →
Q9JK30 — 1.000 Q9JK30 →
Q4R180 — 1.000 Q4R180 →
Q2TB18 — 0.987 Q2TB18 →
Q5RCY5 — 0.986 Q5RCY5 →
Q566H4 — 0.986 Q566H4 →
Q86VS3 — 0.986 Q86VS3 →
Q6AZT6 — 0.985 Q6AZT6 →
Q9BPX3 — 0.985 Q9BPX3 →
FANCI Fanconi anemia group I protein 0.985 landscape →
Q5K651 — 0.984 Q5K651 →
Q6DDZ9 — 0.983 Q6DDZ9 →
Q8C9J3 — 0.983 Q8C9J3 →
Q80W92 — 0.983 Q80W92 →
Q0IY07 — 0.983 Q0IY07 →
Q8NA54 — 0.983 Q8NA54 →
Q95JW3 — 0.983 Q95JW3 →
Q96FV9 — 0.983 Q96FV9 →
A8C754 — 0.982 A8C754 →
Q14CX7 — 0.982 Q14CX7 →
Q9YHB5 — 0.982 Q9YHB5 →
Q8NE18 — 0.982 Q8NE18 →
Q8BMG7 — 0.982 Q8BMG7 →
A2VE70 — 0.982 A2VE70 →
Q7Z392 — 0.982 Q7Z392 →
Q8R3N6 — 0.982 Q8R3N6 →
Q6ZQL4 — 0.982 Q6ZQL4 →
Q66L58 — 0.982 Q66L58 →
Q6DFC6 — 0.982 Q6DFC6 →